Taraxeryl acetate
CAS No. 2189-80-2
Taraxeryl acetate ( —— )
产品货号. M30896 CAS No. 2189-80-2
Taraxeryl acetate shows the significant antiviral activity against herpes simplex virus (type II). It has less effect on cell cycle arrest and apoptosis of AGS cells than taraxerol.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1682 | 有现货 |
|
| 10MG | ¥2717 | 有现货 |
|
| 25MG | ¥4548 | 有现货 |
|
| 50MG | ¥6845 | 有现货 |
|
| 100MG | ¥9990 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Taraxeryl acetate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Taraxeryl acetate shows the significant antiviral activity against herpes simplex virus (type II). It has less effect on cell cycle arrest and apoptosis of AGS cells than taraxerol.
-
产品描述Taraxeryl acetate shows the significant antiviral activity against herpes simplex virus (type II). It has less effect on cell cycle arrest and apoptosis of AGS cells than taraxerol. A. roxburghiana has antidiabetic activity, could be attributed due to PTP1B inhibition by its triterpene constituents, betulin, betulinic acid and Taraxeryl acetate.
-
体外实验Taraxerol acetate(10-150?μM; 24 or 48 hours)induces a dose- and time-dependent cytotoxic effects in the U87 cells, exhibits IC50 values of 34.2 and 28.4?μM, at 24 and 48 h, respectively.Taraxerol acetate(10, 50 and 150?μM; 24 hours)induces cell apoptosis, the percentage of apoptotic cells increased from 7.3% in the control cells, to 16.1, 44.1 and in the 10, 50 and 150?μM taraxerol acetate-treated cells, respectively. Furthermore, taraxerol acetate treatment led to sub-G1?cell cycle arrest with a corresponding decrease in the number of S-phase cells.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number2189-80-2
-
分子量468.8
-
分子式C32H52O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
S1p-receptor-agonist...
S1P 受体激动剂。
-
GPR183
GPR183是一种趋化受体,以其在B细胞成熟中的作用而闻名,内源性配体是氧甾醇7α,25-二羟基胆固醇(7α,25-OHC)。 GPR183可用于炎症性肠病(IBD)的研究。
-
FEN1 Inhibitor C2
FEN1-IN-4 是人皮瓣核酸内切酶 1 (hFEN1) 的抑制剂。FEN1 抑制剂 C2 抑制选择性损害缺乏 Cdc4 和 Mre11a 的结肠癌细胞的增殖,这两种细胞在结直肠癌中经常发生突变。
021-51111890
购物车()
sales@molnova.cn

